Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 4/20 | 0.49 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | HTT | P42858 | 4/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.47 |
| ▸ | PKM | P14618 | 2/20 | 0.47 |
| ▸ | NR2F2 | P24468 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.47 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23265178 | 0.91 | KDM1A (0.43) | KDM1AMAPTHTTNPSR1MEN1 | |
| SCHEMBL13212473 | 0.91 | MAPT (0.48) | KDM1AMAPTHTTNPSR1MEN1 | |
| SCHEMBL1101998 | 0.90 | KDM1A (0.49) | KDM1AMAPTHTTNPSR1MEN1 | |
| SCHEMBL14208031 | 0.88 | KDM1A (0.47) | KDM1AMAPTHTTNPSR1MEN1 | |
| SCHEMBL293951 | 0.86 | KDM1A (0.61) | KDM1AMAPTHTTNPSR1KMT2A | |
| SCHEMBL29557425 | 0.86 | KDM1A (0.61) | KDM1AMAPTHTTNPSR1KMT2A | |
| SCHEMBL14947365 | 0.84 | KDM1A (0.59) | KDM1AMAPTNPSR1MAPK1LMNA | |
| SCHEMBL14947368 | 0.82 | PIM1 (0.54) | KDM1AMAPTNPSR1MAPK1LMNA | |
| SCHEMBL23954334 | 0.82 | PIM1 (0.54) | KDM1AMAPTNPSR1MAPK1LMNA | |
| SCHEMBL13067104 | 0.82 | CYP2D6 (0.53) | KDM1AMAPTHTTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1883987-A1 | SUBSTITUTED PHENOTHIAZINE REDOX SHUTTLES FOR RECHARGEABLE LITHIUM-ION CELL | 3M Innovative Properties Company (US) | 2008-02-06 | — | — | EP | claimed |
| WO-2006124738-A1 | SUBSTITUTED PHENOTHIAZINE REDOX SHUTTLES FOR RECHARGEABLE LITHIUM-ION CELL | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2006-11-23 | — | — | WO | claimed |
| US-20060263697-A1 | Substituted phenothiazine redox shuttles for rechargeable lithium-ion cell | 3M INNOVATIVE PROPERTIES COMPANY | 2006-11-23 | — | — | US | claimed |
| US-11233206-B2 | Phosphorescent PtAg2 complex, preparation method therefor and use thereof | FUJIAN INSTITUTE OF RESEARCH ON THE STRUCTURE OF MATTER, CHINESE ACADEMY OF SCIENCES (CN) | 2022-01-25 | — | — | US | disclosed |
| US-20210115327-A1 | PHOSPHORESCENT PTM3 HETEROTETRANUCLEAR COMPLEX, PREPARATION METHOD AND USE THEREOF | FUJIAN INSTITUTE OF RESEARCH ON THE STRUCTURE OF MATTER, CHINESE ACADEMY OF SCIENCES (CN) | 2021-04-22 | — | — | US | disclosed |
| WO-2019201213-A1 | PHOSPHORESCENT PTM3 HETEROTETRANUCLEAR COMPLEX, PREPARATION METHOD AND USE THEREOF | 中国科学院福建物质结构研究所 | 2019-10-24 | — | — | WO | disclosed |
| US-20190319200-A1 | PHOSPHORESCENT PtAg2 COMPLEX, PREPARATION METHOD THEREFOR AND USE THEREOF | FUJIAN INSTITUTE OF RESEARCH ON THE STRUCTURE OF MATTER, CHINESE ACADEMY OF SCIENCES (CN) | 2019-10-17 | — | — | US | disclosed |
| US-9099657-B2 | Photoelectric conversion element and solar cell | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2015-08-04 | — | — | US | disclosed |
| US-8471143-B2 | Photoelectric conversion element and solar cell | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2013-06-25 | — | — | US | disclosed |
| US-8410356-B2 | Photoelectric conversion element and solar cell | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2013-04-02 | — | — | US | disclosed |
| EP-1883987-B1 | SUBSTITUTED PHENOTHIAZINE REDOX SHUTTLES FOR RECHARGEABLE LITHIUM-ION CELL | 3M INNOVATIVE PROPERTIES CO (US) | 2012-02-22 | — | — | EP | disclosed |
| US-7615312-B2 | Electrolytic cells; phenothiazine compound has oxidation potential above positive electrode recharged potential and serves as cyclable redox chemical shuttle providing cell overcharge protection | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2009-11-10 | — | — | US | disclosed |
| EP-1883987-A1 | SUBSTITUTED PHENOTHIAZINE REDOX SHUTTLES FOR RECHARGEABLE LITHIUM-ION CELL | 3M Innovative Properties Company (US) | 2008-02-06 | — | — | EP | disclosed |
| US-20060263697-A1 | Substituted phenothiazine redox shuttles for rechargeable lithium-ion cell | 3M INNOVATIVE PROPERTIES COMPANY | 2006-11-23 | — | — | US | disclosed |
| WO-2006124738-A1 | SUBSTITUTED PHENOTHIAZINE REDOX SHUTTLES FOR RECHARGEABLE LITHIUM-ION CELL | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2006-11-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190319200-A1 | PHOSPHORESCENT PtAg2 COMPLEX, PREPARATION METHOD THEREFOR AND USE THEREOF | GNG2, PLEKHG3, MON2 | KDM1A 4644/4885MAPT 1116/4885HTT 3622/4885 |
| US-11233206-B2 | Phosphorescent PtAg2 complex, preparation method therefor and use thereof | GNG2, PLEKHG3, MON2 | KDM1A 4644/4885MAPT 1116/4885HTT 3622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.